KR880011063A - 프로피올로페논 유도체 - Google Patents
프로피올로페논 유도체 Download PDFInfo
- Publication number
- KR880011063A KR880011063A KR1019880002846A KR880002846A KR880011063A KR 880011063 A KR880011063 A KR 880011063A KR 1019880002846 A KR1019880002846 A KR 1019880002846A KR 880002846 A KR880002846 A KR 880002846A KR 880011063 A KR880011063 A KR 880011063A
- Authority
- KR
- South Korea
- Prior art keywords
- hydroxy
- hydrogen
- compound
- lower alkyl
- formula
- Prior art date
Links
- JITPLZPWKYUTDM-UHFFFAOYSA-N 1-phenylprop-2-yn-1-one Chemical class C#CC(=O)C1=CC=CC=C1 JITPLZPWKYUTDM-UHFFFAOYSA-N 0.000 title claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 56
- 239000001257 hydrogen Substances 0.000 claims 56
- 150000001875 compounds Chemical class 0.000 claims 44
- 125000000217 alkyl group Chemical group 0.000 claims 41
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 30
- 150000002431 hydrogen Chemical class 0.000 claims 26
- -1 N, N-diisopropyl-3- (2-hydroxy-5-methylbenzoyl) -propionamide Chemical compound 0.000 claims 23
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 13
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 11
- 238000000034 method Methods 0.000 claims 10
- 239000002253 acid Substances 0.000 claims 7
- 125000004414 alkyl thio group Chemical group 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 208000007107 Stomach Ulcer Diseases 0.000 claims 5
- 125000003282 alkyl amino group Chemical group 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 208000000718 duodenal ulcer Diseases 0.000 claims 5
- 201000005917 gastric ulcer Diseases 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical group COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 claims 4
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims 4
- PAZRPPFUVZPPCS-UHFFFAOYSA-N 4-(1,3-benzodioxol-5-yl)-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)C1=CC=C2OCOC2=C1 PAZRPPFUVZPPCS-UHFFFAOYSA-N 0.000 claims 4
- 239000013543 active substance Substances 0.000 claims 4
- 125000002947 alkylene group Chemical group 0.000 claims 4
- 125000005530 alkylenedioxy group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 125000006239 protecting group Chemical group 0.000 claims 4
- DVYJGHJRGDKUOY-UHFFFAOYSA-N 4-methoxy-1-(3-methylphenyl)but-2-yn-1-one Chemical compound COCC#CC(=O)C1=CC=CC(C)=C1 DVYJGHJRGDKUOY-UHFFFAOYSA-N 0.000 claims 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 3
- 150000007513 acids Chemical class 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- JTKDXSMMJBGRQD-UHFFFAOYSA-N 4-hydroxy-4-(2-methoxy-6-phenylmethoxyphenyl)but-2-ynoic acid Chemical compound COC1=CC=CC(OCC=2C=CC=CC=2)=C1C(O)C#CC(O)=O JTKDXSMMJBGRQD-UHFFFAOYSA-N 0.000 claims 2
- BDWYNRUHYHPGFU-UHFFFAOYSA-N 4-methoxy-4-methyl-1-(3-methylphenyl)pent-2-yn-1-one Chemical compound COC(C)(C)C#CC(=O)C1=CC=CC(C)=C1 BDWYNRUHYHPGFU-UHFFFAOYSA-N 0.000 claims 2
- 230000006806 disease prevention Effects 0.000 claims 2
- 230000027119 gastric acid secretion Effects 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- AFENDNXGAFYKQO-VKHMYHEASA-N (S)-2-hydroxybutyric acid Chemical compound CC[C@H](O)C(O)=O AFENDNXGAFYKQO-VKHMYHEASA-N 0.000 claims 1
- BYLJURYDPKPQBZ-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-yl)-4-hydroxybut-2-yn-1-one Chemical compound OCC#CC(=O)C1=CC=C2OCOC2=C1 BYLJURYDPKPQBZ-UHFFFAOYSA-N 0.000 claims 1
- LBGDMCMFZUWEQZ-UHFFFAOYSA-N 1-(4-chlorophenyl)-4-hydroxybut-2-yn-1-one Chemical compound OCC#CC(=O)C1=CC=C(Cl)C=C1 LBGDMCMFZUWEQZ-UHFFFAOYSA-N 0.000 claims 1
- FGFCHQLDHPBBHA-UHFFFAOYSA-N 1-(4-fluorophenyl)-4-hydroxybut-2-yn-1-one Chemical compound OCC#CC(=O)C1=CC=C(F)C=C1 FGFCHQLDHPBBHA-UHFFFAOYSA-N 0.000 claims 1
- LHLDLBINFPOOJM-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethyl 4-(1,3-benzodioxol-5-yl)-4-oxobut-2-ynoate Chemical compound COCCOCCOC(=O)C#CC(=O)C1=CC=C2OCOC2=C1 LHLDLBINFPOOJM-UHFFFAOYSA-N 0.000 claims 1
- ZBNKLKFXEUOMTH-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethyl 4-(4-methoxyphenyl)-4-oxobut-2-ynoate Chemical compound COCCOCCOC(=O)C#CC(=O)C1=CC=C(OC)C=C1 ZBNKLKFXEUOMTH-UHFFFAOYSA-N 0.000 claims 1
- GYSCJNVDBKWABP-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethyl 4-oxo-4-(3,4,5-trimethoxyphenyl)but-2-ynoate Chemical compound COCCOCCOC(=O)C#CC(=O)C1=CC(OC)=C(OC)C(OC)=C1 GYSCJNVDBKWABP-UHFFFAOYSA-N 0.000 claims 1
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 1
- KXVPKRFLLJHURF-UHFFFAOYSA-N 4-(1-ethoxyethoxy)-1-(2,3,4-trimethoxyphenyl)but-2-yn-1-one Chemical compound CCOC(C)OCC#CC(=O)C1=CC=C(OC)C(OC)=C1OC KXVPKRFLLJHURF-UHFFFAOYSA-N 0.000 claims 1
- PSADZENFJWPVLG-UHFFFAOYSA-N 4-(1-ethoxyethoxy)-1-(4-fluorophenyl)but-2-yn-1-one Chemical compound CCOC(C)OCC#CC(=O)C1=CC=C(F)C=C1 PSADZENFJWPVLG-UHFFFAOYSA-N 0.000 claims 1
- HSFBDVDTGCGJBZ-UHFFFAOYSA-N 4-(2,5-dimethoxyphenyl)-4-oxobutanoic acid Chemical compound COC1=CC=C(OC)C(C(=O)CCC(O)=O)=C1 HSFBDVDTGCGJBZ-UHFFFAOYSA-N 0.000 claims 1
- OMTDIBZSUZNVJK-UHFFFAOYSA-N 4-(4-methoxyphenyl)-4-oxobutanoic acid Chemical compound COC1=CC=C(C(=O)CCC(O)=O)C=C1 OMTDIBZSUZNVJK-UHFFFAOYSA-N 0.000 claims 1
- ZKASIXNQCZVAAX-UHFFFAOYSA-N 4-hydroxy-1-(2,3,4-trimethoxyphenyl)but-2-yn-1-one Chemical compound COC1=CC=C(C(=O)C#CCO)C(OC)=C1OC ZKASIXNQCZVAAX-UHFFFAOYSA-N 0.000 claims 1
- DXGYNPZYNMZNFZ-UHFFFAOYSA-N 4-hydroxy-1-(3,4,5-trimethoxyphenyl)but-2-yn-1-one Chemical compound COC1=CC(C(=O)C#CCO)=CC(OC)=C1OC DXGYNPZYNMZNFZ-UHFFFAOYSA-N 0.000 claims 1
- ULOTYUPDPPQIGZ-UHFFFAOYSA-N 4-hydroxy-1-(3,4,5-trimethoxyphenyl)pent-2-yn-1-one Chemical compound COC1=CC(C(=O)C#CC(C)O)=CC(OC)=C1OC ULOTYUPDPPQIGZ-UHFFFAOYSA-N 0.000 claims 1
- BFVVMRRQWCJBAY-UHFFFAOYSA-N 4-hydroxy-1-(4-methoxyphenyl)but-2-yn-1-one Chemical compound COC1=CC=C(C(=O)C#CCO)C=C1 BFVVMRRQWCJBAY-UHFFFAOYSA-N 0.000 claims 1
- NYDSATNBJPHNRB-UHFFFAOYSA-N 4-hydroxy-1-(4-methylphenyl)but-2-yn-1-one Chemical compound CC1=CC=C(C(=O)C#CCO)C=C1 NYDSATNBJPHNRB-UHFFFAOYSA-N 0.000 claims 1
- FCWQANOICITUEK-UHFFFAOYSA-N 4-hydroxy-1-(4-methylsulfanylphenyl)but-2-yn-1-one Chemical compound CSC1=CC=C(C(=O)C#CCO)C=C1 FCWQANOICITUEK-UHFFFAOYSA-N 0.000 claims 1
- FYLGRSWUSRVMHD-UHFFFAOYSA-N 4-methoxy-1-(4-methoxyphenyl)-4-methylpent-2-yn-1-one Chemical compound COC1=CC=C(C(=O)C#CC(C)(C)OC)C=C1 FYLGRSWUSRVMHD-UHFFFAOYSA-N 0.000 claims 1
- WOSCTGONARAZFQ-UHFFFAOYSA-N 4-oxo-4-(2,3,4-trimethoxyphenyl)butanoic acid Chemical compound COC1=CC=C(C(=O)CCC(O)=O)C(OC)=C1OC WOSCTGONARAZFQ-UHFFFAOYSA-N 0.000 claims 1
- VBPGSDAYADHUML-UHFFFAOYSA-N 4-oxo-4-(3,4,5-trimethoxyphenyl)butanoic acid Chemical compound COC1=CC(C(=O)CCC(O)=O)=CC(OC)=C1OC VBPGSDAYADHUML-UHFFFAOYSA-N 0.000 claims 1
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 125000003302 alkenyloxy group Chemical group 0.000 claims 1
- 125000005108 alkenylthio group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000005133 alkynyloxy group Chemical group 0.000 claims 1
- 125000005109 alkynylthio group Chemical group 0.000 claims 1
- 150000007514 bases Chemical class 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- LUEHNHVFDCZTGL-UHFFFAOYSA-N but-2-ynoic acid Chemical compound CC#CC(O)=O LUEHNHVFDCZTGL-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 210000004211 gastric acid Anatomy 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- ZRXFZIUWASCOSM-UHFFFAOYSA-N methyl 4-(2,5-dimethoxyphenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC(OC)=CC=C1OC ZRXFZIUWASCOSM-UHFFFAOYSA-N 0.000 claims 1
- MNJVMENDEQYUNB-UHFFFAOYSA-N methyl 4-(4-fluorophenyl)-4-oxobut-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=C(F)C=C1 MNJVMENDEQYUNB-UHFFFAOYSA-N 0.000 claims 1
- VEIQXRUUKUMXBH-UHFFFAOYSA-N methyl 4-oxo-4-(2,3,4-trimethoxyphenyl)but-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC=C(OC)C(OC)=C1OC VEIQXRUUKUMXBH-UHFFFAOYSA-N 0.000 claims 1
- ZJIYVBNWDDZRMJ-UHFFFAOYSA-N methyl 4-oxo-4-(3,4,5-trimethoxyphenyl)but-2-ynoate Chemical compound COC(=O)C#CC(=O)C1=CC(OC)=C(OC)C(OC)=C1 ZJIYVBNWDDZRMJ-UHFFFAOYSA-N 0.000 claims 1
- 125000005699 methyleneoxy group Chemical group [H]C([H])([*:1])O[*:2] 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 1
- 229940080818 propionamide Drugs 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/313—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/603—Unsaturated compounds containing a keto groups being part of a ring of a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
- C07C45/515—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an acetalised, ketalised hemi-acetalised, or hemi-ketalised hydroxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
- C07C49/796—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
- C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/86—Ketones containing a keto group bound to a six-membered aromatic ring containing —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (41)
- 일반식(Ⅰ)의 프로피올로페논 유도체, 및 일반식(Ⅰ)의 산성 화합물과 염기와의 약제학적으로 사용가능한 염 및 일반식(Ⅰ)의 염기성 화합물과 산과의 약제학적으로 사용가능한 염.상기 식에서 R1,R2,R3,R4및 R5는 각각 수소, 할로겐, 저급알킬, 저급알콕시-저급알킬, 하이드록시, 저급알콕시, 저급알케닐옥시, 저급알키닐옥시, 저급알콕시-저급알콕시, 아실옥시, 아릴-저급알콕시, 저급알킬티오, 저급알콕시-저급알킬티오, 저급알케닐티오, 저급알키닐티오, 아릴-저급알킬티오, 또는 임의로 치환된 아미노 또는 트리플루오로메틸을 나타내거나, 또는 이들 치환체중 서로 인접하는 2개는 이들이 부착되어 있는 탄소원자와 함께 결합하여 5-내지 7-원 환을 나타내고, 단, 여기에서 치환체 R1내지 R5중 2개 이상은 수소를 나타내고 1개 이상은 수소가 아니며 ; R6는 수소 또는 저급알킬을 나타내거나 또는 다음 일반식의 잔기를 나타내며, (a) -COOR7, (b) -CONR8R9, (c) -C(R10)=0, (d) -C(R11)(OR|12)2, (e) -C(OR13)3또는 (f) -C(R14)(R15)OR16R7은 수소, 저급알킬, 저급알케닐, 저급알콕시-저급알킬, 저급알콕시-저급알콕시-저급알킬, 아릴 또는 아릴-저급알킬을 나타내고 ; R8및 R9은 각각 수소 또는 저급알킬을 나타내거나, 또는 R8및 R9가 질소원자와 함께 결합하여 5- 내지 7-원 포화된 헤테로사이클릭 잔기를 나타내며 : R10은 수소, 저급알킬, 아릴 또는 아릴-저급알킬을 나타내고 ; R11은 수소, 저급알킬, 아릴 또는 아릴-저급알킬을 나타내며 ; R12는 저급알킬 또는 저급알콕시-저급알킬을 나타내고 ; R13은 저급알킬을 나타내며 ; R14및 R15는 각각 수소, 저급알킬, 아릴 또는 아릴-저급알킬을 나타내고 ; R16은 수소, 저급알킬, 저급알콕시-저급알킬, 저급알케닐, 저급알키닐, 아실 또는 아릴-저급알킬을 나타내며 ; 단, 여기에서 4-메톡시-1-(3-메틸페닐)-2-부틴-1-온 ; 4-메톡시-1-(4-메톡시페닐)-4-메틸-2-펜틴-1-온 ; 4-메톡시-4-메틸-1-(3-메틸페닐)-2-펜틴-1-온 ; 메틸 3-(2,6-디메톡시벤조일)프로피올레이트 및 N,N-디이소프로필-3-(2-하이드록시-5-메틸벤조일) -프로피올아미드는 제외된다.
- 제1항에 있어서, R1,R2,R3,R4및 R5가 각각 수소, 저급알킬, 하이드록시, 저급알콕시, 저급알킬티오 또는 디-저급알킬아미노를 나타내거나, 또는 이들 치환체중 인접하는 2개는 함께 저급알킬렌 또는 저급알킬렌디옥시를 나타내며, 단 치환체 R1내지 R5중 1개 이상은 수소가 아니고 2개 이상을 수소를 나타내는 화합물.
- 제2항에 있어서, R1이 수소를 나타내는 화합물.
- 제3항에 있어서, R1및 R2가 각각 수소를 나타내고 R3,R4및 R5가 각각 저급알콕시를 나타내거나, R1및 R5가 각각 수소를 나타내고 R2,R3및 R4가 각각 저급알콕시를 나타내거나, R1,R3및 R4가 각각 수소를 나타내고 R2및 R5가 각각 저급알콕시를 나타내거나, R1,R2및 R5가 각각 수소를 나타내고 R3및 R4가 함께 저급알킬렌디옥시 또는 저급알킬렌을 나타내거나 또는 R1,R2,R4및 R5가 각각 수소를 나타내고 R3이 할로겐, 저급알킬, 하이드록시, 저급알콕시, 저급알킬티오 또는 디-저급알킬아미노를 나타내며 R6가 일반식 (a), (b), (c), (d), (e) 또는 (f)의 잔기를 나타내며, 여기에서 R7은 수소, 저급알킬, 저급알콕시-저급알콕시-저급알킬, 아릴-저급알킬 또는 저급알케닐을 나타내고, R3및 R9은 각각 저급알킬을 나타내고, R10은 수소를 나타내고, R11은 수소를 나타내며, R12는 저급알킬은 나타내고, R13은 저급알킬을 나타내며, R14는 수소를 나타내고, R15는 수소 또는 저급알킬을 나타내며 R16은 수소, 저급알케닐, 저급알콕시-저급알킬 또는 아실을 나타내는 화합물.
- 제1항 내지 4항중 어느 한 항에 있어서, R6가 일반식 (a), (b), (c), (d) 또는 (f)의 잔기를 나타내고, 여기에서 R7은 수소, 저급알킬, 저급알콕시-저급알콕시-저급알킬, 아릴-저급알킬 또는 저급알케닐을 나타내고, R8및 R9은 각각 저급알킬을 나타내며, R10은 수소를 나타내고, R11은 수소를 나타내며, R12은 저급알킬을 나타내고, R14는 수소를 나타내며, R15은 수소 또는 저급알킬을 나타내고 R16은 수소, 저급알콕시-저급알킬 또는 아실을 나타내는 화합물.
- 제1항 내지 5항중 어느 한 항에 있어서, R1및 R2가 각각 수소를 나타내고 R3,R4및 R5가 각각 메톡시를 나타내거나, R1및 R5가 각각 수소를 나타내고 R2,R3및 R4가 각각 메톡시를 나타내거나, R1,R3및 R4가 각각 수소를 나타내고 R2및 R5가 각각 메톡시를 나타내거나, R1,R2및 R5가 각각 수소를 나타내고 R3및 R4가 함께 메틸렌디옥시를 나타내거나 또는 R1,R2,R4및 R5가 각각 수소를 나타내고 R3이 염소, 불소, 메틸, 하이드록시, 메톡시 또는 메틸티오를 나타내며 R6가 일반식 (a), (b) 또는 (f)의 잔기를 나타내며, 여기에서 R7은 수소, 메틸 또는 메톡시에톡시에틸을 나타내고, R8및 R9은 각각 메틸을 나타내며, R14는 수소를 나타내고, R15는 수소 또는 메틸을 나타내며 R16는 수소 또는 1-에톡시에틸을 나타내는 화합물.
- 제1항에 있어서, 3-[3,4-(메틸렌옥시)벤조일]프로피올산인 화합물.
- 제1항에 있어서, 4-하이드록시-1-(3,4,5-트리메톡시페닐)-2-부틴-1-온인 화합물.
- 제1항에 있어서, 3-(4-메톡시벤조일)프로피올산인 화합물.
- 제1항에 있어서, 메틸 3-(2,3,4-트리메톡시벤조일)프로피올레이트인 화합물.
- 제1항에 있어서, 메틸 3-(4-하이드록시벤조일)프로피올레이트인 화합물.
- 제1항에 있어서, 2-(2-메톡시에톡시)에틸 3-(3,4,5-트리메톡시벤조일)-프로피올레이트인 화합물.
- 제1항에 있어서, 2-(2-메톡시에톡시)에틸 3-(4-메톡시벤조일)-프로피올레이트인 화합물.
- 제1항에 있어서, 메틸 3-(2,5-디메톡시벤조일)프로피올레이트인 화합물.
- 제1항에 있어서, 3-(2,5-디메톡시벤조일)프로피올산인 화합물.
- 제1항에 있어서, 2-(2-메톡시에톡시)에틸 3-[3,4-(메틸렌디옥시)벤조일]프로피올레이트인 화합물.
- 제1항에 있어서, 3-(2,3,4-트리메톡시벤조일)프로피올산 ; 3-(3,4,5-트리메톡시벤조일)프로피올산 ; 메틸 3-(4-플루오로벤조일)프로피올레이트 ; 메틸 3-(3,4,5-트리메톡시벤조일)프로피올레이트 ; N, N-디메틸-3-(3,4,5-트리메톡시벤조일)프로피올아미드 ; 1-(4-플루오로페닐)-4-하이드록시-2-부틴-1-온 ; 4-하이드록시-1- (4-메틸페닐)-2-부틴-1-온 ; 4-(1-에톡시에톡시)-1-(4-플루오로페닐)-2-부틴-1-온 ; 1-(4-클로로페닐)-4-하이드록시-2-부틴-1-온 ; 4-하이드록시-1-(4-메톡시 페닐)-2-부틴-1-온 ; 4-하이드록시-1-[3,4-(메틸렌디옥시)페닐]-2-부틴-1-온 ; 4-하이드록시-1-(3,4,5-트리메톡시페닐)-2-펜틴-1-온 ; 4-(1-에톡시에톡시)-1-(2,3,4-트리메톡시페닐)-2-부틴-1-온 ; 4-하이드록시-(2,3,4-트리메톡시페닐)-2-부틴-1-온 ; 및 4-하이드록시-1-[4-(메틸티오)페닐]-2-부틴-1-온중에서 선택되는 화합물.
- 일반식(Ⅱ)의 화합물.상기 식에서, R1,R2,R3,R4및 R5는 제1항에서 정의한 바와 같고, R6'는 제1항에서 정의한 일반식 (a), (b), (c), (d) 또는 (e)의 잔기 또는 일반식 -C(R14) (R15)CR16'(f')의 잔기를 나타내며, 여기에서 R14및 R15는 제1항에서 정의한 바와 같고 R16'는 제1항에서 R16에 대해 정의한 바와 같지만, 단 R14및/또는 R|15가 수소를 나타내는 경우에는, 수소를 나타내지 않으며, 단 여기에서 에틸 4-(3,5-디메톡시페닐)-4-하이드록시-2-부티노에이트 ; 에틸 4-(2,5-디메톡시페닐)-4-하이드록시-2-부티노에이트 ; 에틸 4-(2-메톡시페닐)-4-하이드록시-2-부티노에이트 ; 메틸 4-(2-벤질옥시-6-메톡시페닐)-4-하이드록시-2-부티노에이트 ; 4-(2-벤질옥시-6-메톡시페닐)-4-하이드록시-2-부티노산 ; 및 4-(2,6-디메톡시페닐)-4-하이드록시-2-부티노산은 제외된다.
- 제18항에 있어서, R1,R2,R3,R4및 R5가 각각 수소, 저급알킬, 하이드록시, 저급알콕시, 저급알킬티오 또는 디-저급알킬아미노를 나타내거나 이들 치환체중 인접하는 2개는 함께 저급알킬렌 또는 저급알킬렌디옥시를 나타내는데, 단, 치환체 R1내지 R5중 1개 이상은 수소가 아니고 2개 이상은 수소를 나타내는 화합물.
- 제19항에 있어서, R1이 수소를 나타내는 화합물.
- 제20항에 있어서, R1및 R2가 각각 수소를 나타내고 R3,R4및 R5가 각각 저급알콕시를 나타내거나, R1및 R5가 각각 수소를 나타내고 R2,R3및 R4가 각각 저급알콕시를 나타내거나, R1,R2및 R5가 각각 수소를 나타내고 R3및 R4가 함께 저급알킬렌디옥시 또는 저급알킬렌을 나타내거나 또는 R1,R2,R4및 R5가 각각 수소를 나타내고 R3가 할로겐, 저급알킬, 하이드록시, 저급알콕시, 저급알킬티오 또는 디-저급알킬아미노를 나타내는 화합물.
- 제18항 내지 21항중 어느 한 항에 있어서, R6'가 제1항에서 정의된 일반식 (a)의 잔기를 나타내는 화합물.
- 제22항에 있어서, R7이 저급알킬 또는 저급알콕시-저급알콕시-저급알킬을 나타내는 화합물.
- 제18항에 있어서, 메틸 4-하이드록시-4-[3,4-(메틸렌디옥시)페닐]-2-부티노에이트인 화합물.
- 제18항에 있어서, 2-(2-메톡시에톡시)에틸 4-하이드록시-4-(3,4,5-트리메톡시페닐)-2-부티노에이트인 화합물.
- 치료학적 활성 물질, 특히 점막-보호 및/또는 위산분비 억제 활성물질로서 사용하기 위한, 제1항 내지 6항 및 8항 내지 25항중 어느 한 항에 따르는 화합물 및 4-메톡시-1-(3-메틸페닐)-2-부틴-1-온, 4-메톡시-1-(4-메톡시페닐)-4-메틸-2-펜틴-1-온, 4-메톡시-4-메틸-1-(3-메틸페닐)-2-펜틴-1-온, 메틸 3-(2,6-디메톡시벤조일)프로피올레이트, N, N-디이소프로필-3-(2-하이드록시-5-메틸벤조일)프로피올아미드, 에틸4-(3,5-디 메톡시페닐)-4-하이드록시-2-부티노에이트, 에틸 4- (2,5-디메톡시페닐)-4-하이드록시-2-부티노에이트, 에틸 4-(2-메톡시페닐)-4-하이드록시-2-부티노에이트, 메틸 4-(2-벤질옥시-6-메톡시페닐)-4-하이드록시-2-부티 노에이트, 4-(2-벤질옥시-6-메톡시페닐)-4-하이드록시-2-부티노산 및 4-(2,6-디메톡시페닐)-4-하이드록시-2-부티노산.
- 치료학적 활성물질로서, 특히 점막-보호 및/또는 위산 분비-억제 활성물질로서 사용하기 위한 3-[3, 4-(메틸렌디옥시) 벤조일]프로피 올산.
- a) 일반식 (Ⅱ)의 화합물은 산화시키거나 ; b) 일반식 (Ⅲ)의 화합물로부터 보호그룹을 제거하거나 ; c) 일반식 (Ⅳ)의 화합물을 일반식 (V)의 화합물과 반응시키거나 , d) R6가 제1항에서 정의된 바와 같이 일반식 (a)의 잔기를 나타내며 R7은 수소가 아닌 일반식 (I)의 화합물을 상용하는 카복실산으로 분해시키거나 ; e) R6가 제 1항에서 정의된 바와 같은 일반식 (f)의 잔기를 나타내며, R16은 수소를 나타내는 일반식 (I)의 화합물을 아실화 시키거나 ; f) R6가 제1항에서 정의된 바와 같은 일반식 (d)의 잔기를 나타내는 일반식 (I)의 화합물을 R6가 일반식 (c)의 잔기를 나타내는 일반식 (I)의 상용하는 화합물로 전환시키거나 , 또는 g) 일반식 (I)의 산성 화합물을 염기로 또는 일반식 (I)의 염기성 화합물을 산으로 처리하여 약제학적으로 사용가능한 염으로 전환시킴을 특징으로 하여, 제1항 내지 17항중 어느 한 항에 따르는 화합물을 제조하는 방법.상기 식에서, R1, R2,R3, R4및 R5는 제1항에서 정의한 바와 같고, R6'는 수소, 저급알킬, 제1항에서 정의된 일반식 (a), (b), (c), (d) 또는 (e)의 잔기 또는 일반식 -C(R14) (R15)CR16(f')의 잔기를 나타내며, 여기에서 R14및 R15는 제1항에서 정의된 바와 같고, R15는 제1항에서 R16에 대해 정의된 바와 같지만, 단 R14및/또는 R15가 수소를 나타내는 경우에는 수소를 나타내지 않으며, R1,R2',R3',R4'및 R5'는 제1항에서 R1.R2.R3,R4및 R5에 대해 정의된 바와 같고 이들중 최대 3개는 추가로 보호된 하이드록시, 보호된 아미노 또는 보호된 저급알킬아미노를 나타낼 수 있으며, R6'는 제1항에서 정의된 일반식 (a), (b), (c) (d) 또는 (e)의 잔기를 나타내거나 일반식 -C(R14) (R15)CR16'(f')의 잔기를 나타내고, 여기에서 R14및 R15는 제1항에서 정의된 바와 같고 R16'는 제1항에서 R16에 대해 정의된 바와 같으며, 추가로는 보호그룹을 나타낼 수 있으며, R17은 이탈그룹을 나타내며, R6"는 제1항에서 정의된 일반식 (a), (b), (c), (d), (e) 또는 (f)의 잔기를 나타내고, 단, 일반식 (Ⅲ)의 분자는 1개 이상의 보호그룹을 함유한다.
- 제1항에 있어서, 3-[3,4-(메틸렌디옥시)벤조일]프로피올산이 제조되는 방법.
- aa) 일반식 (Ⅵ)의 화합물을 일반식 (Va)의 화합물과 반응시키거나 ; 또는 bb) 일반식 (Ⅶ)의 화합물로부터 보호그룹(들)을 분해시킴을 특징으로 하여, 제18항 내지 25항중 어느 한 항에 따르는 화합물을 제조하는 방법.상기 식에서 R1,R2,R3,R4및 R5는 제1항에서 정의된 바와 같고 : R6iv는 제1항에서 정의된 일반식 (3), (b), (d) 또는 (e)의 잔기 또는 제28항에서 정의된 일반식 (f')의 잔기를 나타내며 ; R1',R2',R3',R4'및 R|5'는 제18항에서 정의된 바와 같고 ; R6v는 제1항에서 정의된 일반식 (a), (b) 또는 (c)의 잔기 또는 일반식 -C(R14) (R15)OR16'"(f'")의 잔기를 나타내며, 여기에서 R7및 R10은 수소가 아니고, R14및 R15는 제18항에서 정의된 바와 같으며 R16'"은 제18항에서 R16'에 대해 정의된 바와 같지만, 단, Rl6'"은 추가로 보호그룹을 나타낼 수 있으며, R18은 보호그룹을 나타낸다.
- 제30항에 있어서, 방법 aa)를, 일반식 (Va)의 화합물 대신에 이의 반응성 유도체를 사용하여 수행하는 방법.
- 제31항에 있어서, 일반식 (Va) 화합물의 트리메틸실릴 유도체를 사용하는 방법.
- 제1항 내지 6항 및 8항 내지 25항중 어느 한 항에 따르는 화합물 또는 4-메톡시-1-(3-메틸페닐)-2-부틴-1-온, 4-메톡시-1-(4-메톡시페닐)-4-메틸-2-펜틴-1-온, 4-메톡시-4-메틸-1-(3-메틸페닐)-2-펜틴-1-온, 메틸 3-(2,6-디메톡시벤조일)프로피올레이트 N, N-디이소프로필-3-(2-하이드록시-5-메틸벤조일)프로피올아미드, 에틸 4-(3,5-디메톡시페닐)-4-하이드록시-2-부티노에이트, 에틸 4-(2,5-디메톡시페닐)-4-하이드록시-2-부티노에이트, 에틸 4-(2-메톡시페닐)-4-하이드록시-2-부티노에이트, 메틸 4-(2-벤질옥시-6-메톡시페닐)-4-하이드록시-2-부티노에이 트, 4-(2-벤질옥시-6-메톡시페닐)-4-하이드록시-2-부티노산 또는 4-(2,6-디메톡시페닐)-4-하이드록시-2-부티노산, 및 치료학적으로 불활성인 부형제를 함유하는 약제.
- 3-[3,4-(메틸렌디옥시)-벤조일]프로피올산 및 치료학적으로 불활성인 부형제를 함유하는 약제.
- 제33항 또는 34항에 있어서, 위궤양 및/또는 십이지장궤양을 억제 및 예방하기 위한, 점막-보호 및/또는 위산 분비-억제 특성-을 갖는 약제.
- 질병, 특히 위궤양 및/또는 십이지장궤양을 억제 또는 예방하거나, 또는 위궤양 및/또는 십이지장궤양에 대한 약제를 제조하는데 있어서의, 제1항 내지 6항 및 제8항 내지 25항중 어느 한 항에 따르는 화합물, 및 4-메톡시-1- (3-메틸페닐)-2-부틴-1-온, 4-메톡시-1- (4-메톡시페닐)-4-메틸-2-펜틴-1-온, 4-메톡시-4-메틸-1- (3-메틸페닐)-2-펙틴-1-온, 메틸 3-(2,6-디메톡시벤조일)프로피올레이트, N, N-디이소프로필-3-(2-하이드록시-5-메틸벤조일)프로피올아미 드, 에틸 4-(3,5-디메톡시페닐)-4-하이드록시-2-부티노에이트, 에틸 4- (2,5-디메톡시페닐)-4-하이드록시-2-부티노에이트, 에틸4-(2-메톡시페닐)-4-하이드록시-2-부티노에이트, 메틸 4-(2-벤질옥시-6-메톡시페닐)-4-하이드록시-2-부티노에이트, 4-(2-벤질옥시-6-메톡시페닐)-4-하이드록시-2-부티노산 및 4-(2,6-디메톡시페닐)-4-하이드록시-2-부티노산의 용도.
- 질병, 특히 위궤양 및/또는 십이지장궤양을 억제 또는 예방하거나, 또는 위궤양 및/또는 십이지장궤양에 대한 약제를 제조하는데 있어서의, 3-[3,4-(메틸렌디옥시)벤조일]프로피올산의 용도.
- 제28항에 청구된 방법 또는 이의 명백한 화학적으로 동등한 방법에 의해 제조되는, 제1항 내지 17항 중 어느 한 항에 따르는 화합물.
- 제29항에 청구된 방법 또는 이의 명백한 화학적으로 동등한 방법에 의해 제조되는, 3-[3, 4-(메틸렌디옥시)벤조일]프로피 올산.
- 제30항, 31항 또는 37항에 청구된 방법 또는 이의 명백한 화학적으로 동등한 방법에 의해 제조되는, 제18항 내지 25항중 어느 한 항에 따르는 화합물.
- 본 병세서에 기술되어 있는 바와 같은 발명.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH01072/87-7 | 1987-03-20 | ||
CH107287 | 1987-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880011063A true KR880011063A (ko) | 1988-10-26 |
Family
ID=4201794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880002846A KR880011063A (ko) | 1987-03-20 | 1988-03-18 | 프로피올로페논 유도체 |
Country Status (13)
Country | Link |
---|---|
US (1) | US4929741A (ko) |
EP (1) | EP0282898A3 (ko) |
KR (1) | KR880011063A (ko) |
AU (1) | AU1307688A (ko) |
DK (1) | DK49688A (ko) |
FI (1) | FI880812A (ko) |
HU (1) | HUT46644A (ko) |
IL (1) | IL85722A0 (ko) |
MC (1) | MC1916A1 (ko) |
NO (1) | NO881220L (ko) |
PT (1) | PT87024B (ko) |
YU (1) | YU55088A (ko) |
ZA (1) | ZA881808B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990015054A (ko) * | 1997-08-01 | 1999-03-05 | 구광시 | 페닐프로피온산 유도체의 제조방법 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8712200D0 (en) * | 1987-05-21 | 1987-07-22 | Research Corp Ltd | Substituted phenone |
US4847303A (en) * | 1987-11-23 | 1989-07-11 | The Procter & Gamble Company | Tert-butylphenyl compounds useful as anti-inflammatory agents |
MTP1031B (en) * | 1987-12-24 | 1990-10-04 | Orion Yhtymae Oy | New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters |
US5217981A (en) * | 1989-12-18 | 1993-06-08 | G. D. Searle & Co. | LTB4 synthesis inhibitors |
US5223518A (en) * | 1990-09-20 | 1993-06-29 | Merrell Dow Pharmaceuticals Inc. | 1-phenyl-3-aryl-2-propyne-1-one useful as calcium uptake inhibitors |
AU653957B2 (en) * | 1990-09-20 | 1994-10-20 | Merrell Dow Pharmaceuticals Inc. | 1-aryl-3-pyridinyl-2-propene-1-ones |
US5248825A (en) * | 1990-09-20 | 1993-09-28 | Merrell Dow Pharmaceuticals Inc. | Calcium uptake inhibitors |
US5112864A (en) * | 1991-05-30 | 1992-05-12 | G. D. Searle & Co. | PLA2 inhibitors as antiinflammatories |
US5356919A (en) * | 1991-05-30 | 1994-10-18 | G. D. Searle & Co. | Leukotriene B4 synthesis inhibitors |
CA2128991A1 (en) * | 1993-08-02 | 1995-02-03 | Hisao Takayanagi | Benzoylacetylene derivatives |
EP2647372A1 (de) | 2008-09-04 | 2013-10-09 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH | Monoterpene für die Behandlung von Atemwegserkrankungen, insbesondere bronchopulmonalen Erkrankungen |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3754021A (en) * | 1968-05-29 | 1973-08-21 | Merck & Co Inc | 4-keto-4-(3-chloro-4'-cyclohexyl)phenylbutyric acid and related compounds |
BE758735A (fr) * | 1969-11-14 | 1971-05-10 | Hoffmann La Roche | Composes acetyleniques |
EP0022321A1 (en) * | 1979-07-10 | 1981-01-14 | Beecham Group Plc | Benzene derivatives, their preparation and use in pharmaceutical compositions |
FR2481118A1 (fr) * | 1980-04-24 | 1981-10-30 | Roussel Uclaf | Application a titre de medicaments de derives substitues de l'acide phenyl-4-oxo-2-butenoique |
FR2504127B1 (fr) * | 1981-04-17 | 1985-07-19 | Roussel Uclaf | Nouveaux derives d'acides phenyl aliphatique carboxyliques, procede pour leur preparation et leur application comme medicaments |
IT1171604B (it) * | 1981-10-22 | 1987-06-10 | Roussel Maestretti Spa | Derivati di acido 4-fenil-4-ossobuten-2-oico dotati di proprieta' farmacologiche e loro procedimento di preparazione |
IT1169783B (it) * | 1983-08-25 | 1987-06-03 | Roussel Maestretti Spa | Derivati dell' acido 4-fenil 4-osso-buten 2-oico, loro procedimento di preparazione e loro applicazione come prodotti medicinali |
EP0157740B1 (de) * | 1984-04-04 | 1990-06-27 | Ciba-Geigy Ag | Glycidyloxydiketone |
US4624964A (en) * | 1985-03-27 | 1986-11-25 | E. I. Du Pont De Nemours And Company | Aryl oxo-alkynoates as 5-lipoxygenase inhibitors |
US4708966A (en) * | 1986-06-27 | 1987-11-24 | The Procter & Gamble Company | Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation |
-
1988
- 1988-02-01 DK DK049688A patent/DK49688A/da not_active Application Discontinuation
- 1988-02-22 FI FI880812A patent/FI880812A/fi not_active Application Discontinuation
- 1988-03-09 EP EP88103738A patent/EP0282898A3/de not_active Withdrawn
- 1988-03-14 ZA ZA881808A patent/ZA881808B/xx unknown
- 1988-03-14 IL IL85722A patent/IL85722A0/xx unknown
- 1988-03-14 AU AU13076/88A patent/AU1307688A/en not_active Abandoned
- 1988-03-16 HU HU881241A patent/HUT46644A/hu unknown
- 1988-03-17 MC MC881960A patent/MC1916A1/xx unknown
- 1988-03-17 US US07/169,643 patent/US4929741A/en not_active Expired - Fee Related
- 1988-03-18 PT PT87024A patent/PT87024B/pt not_active IP Right Cessation
- 1988-03-18 YU YU00550/88A patent/YU55088A/xx unknown
- 1988-03-18 NO NO881220A patent/NO881220L/no unknown
- 1988-03-18 KR KR1019880002846A patent/KR880011063A/ko not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990015054A (ko) * | 1997-08-01 | 1999-03-05 | 구광시 | 페닐프로피온산 유도체의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
NO881220L (no) | 1988-09-21 |
PT87024A (pt) | 1988-04-01 |
US4929741A (en) | 1990-05-29 |
EP0282898A3 (de) | 1989-10-18 |
EP0282898A2 (de) | 1988-09-21 |
MC1916A1 (fr) | 1989-04-06 |
ZA881808B (en) | 1988-09-20 |
HUT46644A (en) | 1988-11-28 |
FI880812A (fi) | 1988-09-21 |
DK49688A (da) | 1988-09-21 |
YU55088A (en) | 1990-02-28 |
AU1307688A (en) | 1988-09-22 |
FI880812A0 (fi) | 1988-02-22 |
PT87024B (pt) | 1992-07-31 |
IL85722A0 (en) | 1988-08-31 |
DK49688D0 (da) | 1988-02-01 |
NO881220D0 (no) | 1988-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880011063A (ko) | 프로피올로페논 유도체 | |
KR890008137A (ko) | 3-[4(1-치환된-4-피페라지닐)부틸]-4-티아졸리디노 이의 제조방법 및 약제로서의 이의 용도 | |
AT367764B (de) | Verfahren zur herstellung von neuen cephalosporin-derivaten | |
DE3863202D1 (de) | Ester von mit pyrethrumsaeure verwandten cyclopropancarbonsaeuren, verfahren zur ihrer herstellung und ihre verwendung als parasitizide. | |
ATE8144T1 (de) | Indolobenzoxazine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen. | |
EP0168921A3 (en) | Chemical compounds | |
JPS56138181A (en) | Ml-236a and mb-530a derivative | |
JPS52106897A (en) | Synthesis of piperazine derivatives | |
KR960017669A (ko) | 양쪽성 3환식 화합물 | |
JPS57131771A (en) | Novel pyrimidine derivative | |
JPS52133973A (en) | Preparation of optically active lactam derivatives | |
JPS57154183A (en) | Omega-piperazinylalkanoylalkylene dioxybenzenes and their acid addition salts | |
JPS5498755A (en) | Novel butenophenone derivative | |
JPS5690070A (en) | Novel pyrimidine derivative | |
DE59407547D1 (de) | Verfahren zur Herstellung von 2-substituierten 5-Chlorimidazol-4-carbaldehyden | |
KR910011862A (ko) | 티에노벤조크세핀- 및 나프토티오펜- 유도체, 이의 제조를 위한 중간체, 이의 제조방법 및 약제로서 이의 용도 | |
JPS525767A (en) | Preparation of novel organic compounds | |
JPS53111063A (en) | Alpha-phenoxypropionic acid derivatives, their preparation and herbicides | |
JPS5430167A (en) | 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts | |
PL290719A1 (en) | Method of obtaining novel enantiomers constituting derivatives of 2-tetrahydrofurane | |
JPS5492955A (en) | Heterocyclic compound and its preparation | |
JPS5430166A (en) | 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts | |
JPS52102272A (en) | Synthesis of novel benzophenone derivatives | |
JPS5759897A (en) | Thiazolineazatidinone | |
JPS56103180A (en) | Novel quinazoline derivative and its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |